News + Press Releases

OverviewNews + Press ReleasesCompany Info
Nov
1

PlantEXT and the Agricultural Research Organization (ARO-Israel) Isolate Cannabis Compounds That Potentially Decrease Inflammation in the Cytokine Storm of COVID-19

October 29, 2020
Oct
30

Cannabis Movers & Shakers: TILT, Liberty Health, Ikänik Life, PlantEXT, Cann, Organigram

October 30, 2020
jan
24

BB1 Acquisition Corp. Announces Termination of Proposed Qualifying Transaction with PlantExt Ltd.

January 24, 2020
nov
12

Medical Cannabis Plays Chase Investor Interest Amid Downturn

November 12, 2019
aug
19

BB1 Acquisition Corp. Enters Into Definitive Agreement with PlantEXT Ltd. to Complete Business Combination

August 19, 2019
aug
19

BB1 Acquisition Corp. Enters Into Definitive Agreement with PlantEXT Ltd. to Complete Business Combination

August 19, 2019
jul
18

Treating inflammation related conditions with PlantEXT Ltd

July 18, 2019
feb
27

PROFILES BY CANNABIZ SOCIAL PODCAST - DOUG SOMMERVILLE

February 27, 2019
jul
11

Cannabis Growth Opportunity Corporation Announces New Investment in PlantEXT Ltd.

July 11, 2019
jul
10

PlantEXT Engages Beacon Securities Limited for $7-Million USD Brokered Private Placement

July 10, 2019

Investor Contact Information

info@plantext.comwillykruh@plantext.com
Sign up to our newsletter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
PlantEXT

2300 Yonge Street, Suite 1709
Toronto, ON
M4P 1E4

Developing and commercializing the most effective, clinically evidenced medical cannabis formulations that improve the quality of life for patients across the globe.

info@plantext.comTel: 416.640.5353
HomeAboutInvestorsCovid ResearchProductsContact
Copyright © 2020 PlantEXT Ltd. | Disclaimer | Privacy Policy